ASR Vermogensbeheer »

United Therapeutics Corporation shares owned by ASR Vermogensbeheer

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by ASR Vermogensbeheer from 13F filings

Historical chart of ASR Vermogensbeheer investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by ASR Vermogensbeheer consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by ASR Vermogensbeheer

Quarter filed Position value Share count Share price at filing
2026-06-30 $10M 19k 541.77
2026-03-31 $724k 1.2k 592.95
2025-12-31 $581k 1.2k 487.19
2025-09-30 $506k 1.2k 419.17
2025-06-30 $351k 1.2k 287.35
2025-03-31 $378k 1.2k 308.22

More positions owned by ASR Vermogensbeheer

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Micron Technology (MU)
Astrazeneca Ord (AZN)
Applied Materials (AMAT)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Ubs Group SHS (UBS)

View all positions for ASR Vermogensbeheer

Top funds holding United Therapeutics Corporation

BlackRock
venBio Select Advisor
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Renaissance Technologies
Wellington Management Company
Geode Capital Management
Henderson Group
Jupiter Topco
Caption Management
Citadel Advisors
Susquehanna International
Norges Bank Investment Management
Assetmark

View all funds holding United Therapeutics Corporation